CompanyGraph
At a glance
- Depends onUpstream position: supplies 5 industries, depends on 1
- ScaleMarket cap is $3.59B, above the global median of $1.15B
- PositionOperating margin is 71.1%, higher than 95% of its Gold peers (median 19.3%)
- Interpretations11 currently firing — 11
Sign in to view price data.
Sign inThe reported statements, read against the company's own industry.
Financials view
Market Capitalization
3.59BUSDvs all stocks (USD)
Trailing P/E
11.22xvs Gold peers
Revenue (TTM)
686.93MUSDvs all stocks (USD)
Profit Margin
46.09%vs Gold peers
Beta
1.29xvs all stocks
52-Week Change
34.42%vs all stocks
Market Capitalization
3.59BUSDvs all stocks (USD)
Enterprise Value
3.48BUSDvs all stocks (USD)
Trailing P/E
11.22xvs Gold peers
PEG Ratio
0.1713xvs Gold peers
Price to Sales (TTM)
5.17xvs Gold peers
Price to Book (MRQ)
4.00xvs Gold peers
Enterprise to Revenue
5.07xvs Gold peers
Enterprise to EBITDA
7.10xvs Gold peers
Gross Margin
75.76%vs Gold peers
Profit Margin
46.09%vs Gold peers
Operating Margin
71.06%vs Gold peers
Return on Assets (TTM)
32.44%vs Gold peers
Return on Equity (TTM)
44.00%vs Gold peers
Revenue (TTM)
686.93MUSDvs all stocks (USD)
Revenue per Share (TTM)
2.83USDUpdated Jul 19, 2026Quarterly Revenue Growth
63.40%vs Gold peers
Gross Profit (TTM)
506.87MUSDvs all stocks (USD)
EBITDA (TTM)
505.23MUSDvs all stocks (USD)
Net Income (TTM)
316.58MUSDvs all stocks (USD)
Quarterly Earnings Growth (YoY)
66.00%vs Gold peers
Operating Cash Flow (TTM)
332.05MUSDvs all stocks (USD)
Levered Free Cash Flow (TTM)
46.55MUSDvs all stocks (USD)
Trailing Annual Dividend Rate
0.00USDUpdated Jul 19, 2026Trailing Annual Dividend Yield
0.00%vs all stocks
Payout Ratio
0.00%vs Gold peers
Revenue
595.25MUSDFY2025 · Dec 31, 2025Cost of Goods Sold
156.91MUSDFY2025 · Dec 31, 2025Gross Profit
438.34MUSDFY2025 · Dec 31, 2025Operating Income
400.14MUSDvs all stocks (USD)
Pre-tax Income
388.07MUSDFY2025 · Dec 31, 2025Income Tax Expense
117.88MUSDFY2025 · Dec 31, 2025Net Income
270.19MUSDFY2025 · Dec 31, 2025EBIT
388.69MUSDFY2025 · Dec 31, 2025EBITDA (Income Statement)
433.33MUSDFY2025 · Dec 31, 2025Selling, General & Administrative
19.74MUSDFY2025 · Dec 31, 2025Other Operating Expenses
18.46MUSDFY2025 · Dec 31, 2025Non-operating Interest Income
5.18MUSDFY2025 · Dec 31, 2025Non-operating Interest Expense
622.00KUSDFY2025 · Dec 31, 2025EPS (Basic)
1.12USDFY2025 · Dec 31, 2025EPS (Diluted)
1.11USDFY2025 · Dec 31, 2025Basic Shares Outstanding
241.55MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
241.55MSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
270.19MUSDFY2025 · Dec 31, 2025Operating Cash Flow
267.93MUSDFY2025 · Dec 31, 2025Free Cash Flow
52.02MUSDFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
230.88MUSDFY2025 · Dec 31, 2025Income Tax Paid
90.22MUSDFY2025 · Dec 31, 2025Interest Paid
10.93MUSDFY2025 · Dec 31, 2025Starting Profit (CF Statement)
270.19MUSDFY2025 · Dec 31, 2025Depreciation & Amortization
28.01MUSDFY2025 · Dec 31, 2025Deferred Taxes (CF)
16.89MUSDFY2025 · Dec 31, 2025Stock-based Compensation
7.50MUSDFY2025 · Dec 31, 2025Other Non-cash Items
-10.73MUSDFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
-43.24MUSDFY2025 · Dec 31, 2025Change in Accounts Payable (CF)
19.21MUSDFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
-19.90MUSDFY2025 · Dec 31, 2025Capital Expenditures
-215.91MUSDFY2025 · Dec 31, 2025Purchase of Investments
0.00USDFY2025 · Dec 31, 2025Sale of Investments
22.17MUSDFY2025 · Dec 31, 2025Net Investing Cash Flow
-193.74MUSDFY2025 · Dec 31, 2025Long-term Debt Issuance
20.00MUSDFY2025 · Dec 31, 2025Long-term Debt Payments
-31.92MUSDFY2025 · Dec 31, 2025Other Financing Charges
-200.00KUSDFY2025 · Dec 31, 2025Net Financing Cash Flow
-12.12MUSDFY2025 · Dec 31, 2025Shares Outstanding
245.08MSharesUpdated Jul 19, 2026Float Shares
238.31MSharesUpdated Jul 19, 2026% Held by Insiders
2.49%vs all stocks
% Held by Institutions
53.91%vs all stocks
Total Cash (MRQ)
286.99MUSDvs all stocks (USD)
Total Cash per Share (MRQ)
1.17USDUpdated Jul 19, 2026Total Debt (MRQ)
49.14MUSDvs all stocks (USD)
Total Debt to Equity (MRQ)
0.0553xvs Gold peers
Current Ratio (MRQ)
4.87xvs Gold peers
Book Value per Share (MRQ)
3.62USDUpdated Jul 19, 2026Total Assets
957.82MUSDvs all stocks (USD)
Total Current Assets
377.41MUSDFY2025 · Dec 31, 2025Total Liabilities
190.26MUSDFY2025 · Dec 31, 2025Total Non-current Assets
580.40MUSDFY2025 · Dec 31, 2025Total Non-current Liabilities
75.13MUSDFY2025 · Dec 31, 2025Total Current Liabilities
115.13MUSDFY2025 · Dec 31, 2025Cash & Cash Equivalents
230.88MUSDFY2025 · Dec 31, 2025Other Short-term Investments
0.00USDFY2025 · Dec 31, 2025Accounts Receivable
61.08MUSDFY2025 · Dec 31, 2025Inventory
67.90MUSDFY2025 · Dec 31, 2025Accounts Payable
18.45MUSDFY2025 · Dec 31, 2025Short-term Debt
21.47MUSDFY2025 · Dec 31, 2025Deferred Revenue
6.02MUSDFY2025 · Dec 31, 2025Long-term Debt
33.06MUSDFY2025 · Dec 31, 2025Common Stock (Book)
191.79MUSDFY2025 · Dec 31, 2025Retained Earnings
555.43MUSDFY2025 · Dec 31, 2025Total Shareholders' Equity
767.55MUSDvs all stocks (USD)
52-Week Low
10.00USDUpdated Jul 19, 202652-Week High
24.87USDUpdated Jul 19, 202652-Week Change
34.42%vs all stocks
Beta
1.29xvs all stocks
50-Day MA
17.05USDUpdated Jul 19, 2026200-Day MA
16.96USDUpdated Jul 19, 2026Avg 10-Day Volume
53.23KSharesUpdated Jul 19, 2026Avg 30-Day Volume
65.85KSharesUpdated Jul 19, 2026Diluted EPS (TTM)
1.29USDUpdated Jul 19, 2026Other Income / Expense
-16.63MUSDFY2025 · Dec 31, 202511 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsIs this company financially stable?
MRQ Cash Elevated Relative To Total Debt With EBITDA And FCF Elevated Relative To Total Liabilities
Cash covers most of its debt, with earnings high against its liabilities.
Reads
How does this company use capital?
Diagnostic
Elevated EBITDA Margin With Small D&A Gap and Capex Above Depreciation
EBITDA margin reads high with little depreciation charged, and capex above that charge.
Reads
Three Asset-Base Ratios Elevated
It gets more sales from its assets than its industry does, and a lot of profit from them too.
Reads
Cash Backing With Revenue And Income Streaks
Revenue has risen in each of three years, profit in all three, and it holds more cash than debt.
Reads
Cash-Flow Ratios Elevated
More of its sales turn into cash than in its industry, and less of that cash is consumed by reinvestment than at most of its peers.
Reads
Three Margin Ratios Elevated Across Gross, Operating, And Cash-Conversion Levels
Its gross margin and its cash margin are high for its industry, and its operating margin is high outright.
Reads
Industry-Benchmarked Return on Capital Elevated
It earns more on its assets and its equity than its industry, and gets more sales from those assets.
Reads
Three Margin Ratios Elevated Across Gross, Operating, And Net Levels
Its gross and net margins are high for its industry, and its operating margin is high outright.
Reads
ROE, ROA, And Operating ROA Elevated
It earns more on its equity than its industry does, and on its assets too — not on borrowing alone.
Reads
Is this company growing?
Revenue Growth With Elevated Margin
Revenue up in each of five years, while its operating margin stays high.
Reads
How is this stock valued?
High Retained Earnings With Profitability And Equity
Profits kept in the business fund much of what it owns, after five straight profitable years.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Peer Positioning
Operating margin is 71.1%, higher than 95% of its Gold peers (median 19.3%)Significant
Operating margin: 0.71Industry median: 0.19Industry P95: 0.62Peers compared: 58.00
Return on equity is 44%, higher than 95% of its Gold peers (median -8.2%)Significant
Return on equity: 0.44Industry median: -0.08Industry P95: 0.37Peers compared: 58.00
Return on assets is 32.4%, higher than 95% of its Gold peers (median -5.6%)Significant
Return on assets: 0.32Industry median: -0.06Industry P95: 0.28Peers compared: 58.00
Financial Health
Altman Z-Score 14.42: safe zoneNotable
Altman Z-Score: 14.42
High earnings qualityNotable
Earnings Quality Score: 1.40
High structural barrier to entryNotable
Barrier to Entry: 0.79
Supply Chain
Upstream position: supplies 5 industries, depends on 1Notable
Outgoing: 5.00Incoming: 1.00
Scale
Market cap is $3.59B, above the global median of $1.15BNotable
Market cap (USD): 3,591,018,606Global Median: 1,146,734,693.424
Revenue is $686.93M, above the global median of $520.53MNotable
Revenue (USD): 686,928,000Global Median: 520,528,949.311
Levered free cash flow is $46.55M, above the global median of $16.24MNotable
Levered free cash flow (USD): 46,545,876Global Median: 16,239,329.704
Companies that share the same coordination system — how they create, deliver, or capture value.
Henan Zhongfu Industry Co., Ltd.
Tier 1ProductionDepleting ExtractiveFlowRisk
Turk Altin Isletmeleri A.S.
Tier 1ProductionDepleting ExtractiveFlowRule
Turk Altin Isletmeleri Anonim Sirketi
Tier 1ProductionDepleting ExtractiveFlowRule
Peyto Exploration & Development Corp.
Tier 1ProductionDepleting ExtractiveRuleRisk
Paramount Resources Ltd.
Tier 1ProductionDepleting ExtractiveRiskRule
Pingdingshan Tianan Coal Mining Co., Ltd.
Tier 1ProductionDepleting ExtractiveFlowRisk
Almonty Industries Inc.
Tier 1ProductionDepleting ExtractiveFlowRule
Pan African Resources PLC
Tier 1ProductionDepleting ExtractiveFlowRisk
Capricorn Metals Ltd
Tier 1ProductionDepleting ExtractiveFlowRisk
Trimegah Bangun Persada Tbk
Tier 1ProductionDepleting ExtractiveFlowRisk
Companies that share active interpretations — structural patterns currently present in both stocks.
NVIDIA Corporation
11 interpretationsThree Margin Ratios Elevated Across Gross, Operating, And Cash-Conversion LevelsMRQ Cash Elevated Relative To Total Debt With EBITDA And FCF Elevated Relative To Total LiabilitiesHigh Retained Earnings With Profitability And EquityElevated EBITDA Margin With Small D&A Gap and Capex Above DepreciationCash Backing With Revenue And Income StreaksROE, ROA, And Operating ROA ElevatedCash-Flow Ratios ElevatedRevenue Growth With Elevated MarginIndustry-Benchmarked Return on Capital ElevatedThree Margin Ratios Elevated Across Gross, Operating, And Net LevelsThree Asset-Base Ratios Elevated
Catalyst Pharmaceuticals Inc.
10 interpretationsThree Margin Ratios Elevated Across Gross, Operating, And Cash-Conversion LevelsMRQ Cash Elevated Relative To Total Debt With EBITDA And FCF Elevated Relative To Total LiabilitiesHigh Retained Earnings With Profitability And EquityCash Backing With Revenue And Income StreaksROE, ROA, And Operating ROA ElevatedCash-Flow Ratios ElevatedRevenue Growth With Elevated MarginIndustry-Benchmarked Return on Capital ElevatedThree Margin Ratios Elevated Across Gross, Operating, And Net LevelsThree Asset-Base Ratios Elevated
Pharma Research Products Co., Ltd
10 interpretationsThree Margin Ratios Elevated Across Gross, Operating, And Cash-Conversion LevelsMRQ Cash Elevated Relative To Total Debt With EBITDA And FCF Elevated Relative To Total LiabilitiesHigh Retained Earnings With Profitability And EquityCash Backing With Revenue And Income StreaksROE, ROA, And Operating ROA ElevatedCash-Flow Ratios ElevatedRevenue Growth With Elevated MarginIndustry-Benchmarked Return on Capital ElevatedThree Margin Ratios Elevated Across Gross, Operating, And Net LevelsThree Asset-Base Ratios Elevated